Literature DB >> 8707077

Gastric mucosal superoxide dismutases in Helicobacter pylori infection.

J M Götz1, C I van Kan, H W Verspaget, I Biemond, C B Lamers, R A Veenendaal.   

Abstract

BACKGROUND: The mucosal pathology of Helicobacter pylori infection may in part be due to excessive production of reactive oxygen metabolites (ROMs) by phagocytes. The influence of H pylori infection on mucosal superoxide dismutases, some major scavenger enzymes of ROM was investigated. In humans superoxidase dismutase is present in at least two forms-that is, mitochondrial manganese (Mn)-superoxide dismutase and cytoplasmic copper-zinc (CuZn)-superoxide dismutase.
METHODS: The amount and activity of both superoxide dismutases were measured, respectively by enzyme linked immunosorbent assay (ELISA) and spectrophotometrical enzyme activity assay, in gastric biopsy homogenates of patients with normal mucosa (n = 39) and in patients with H pylori related gastritis (n = 71). Infection and gastritis were confirmed by a combination of culture, serology, and histology.
RESULTS: The amount (p < 0.001) and activity (p < or = 0.05) of Mn-superoxide dismutase were increased by about twofold to three-fold, whereas the amount and activity of CuZn-superoxide dismutase showed a slight decrease in gastric mucosa of patients with H pylori gastritis, in both antrum and corpus, compared with normal mucosa of patients without H pylori infection. Mn-superoxide dismutase concentrations in biopsy specimens of histologically normal corpus from patients with an inflamed antrum were significantly higher (p < 0.01) than that of patients with a histologically normal antrum.
CONCLUSION: H pylori infection has a differential effect on mitochondrial and cytoplasmic superoxide dismutase in the gastric mucosa, reflected by a pronounced increase in the cytokine inducible Mn-superoxide dismutase and a marginal decrease in the constitutive CuZn-superoxide dismutase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707077      PMCID: PMC1383104          DOI: 10.1136/gut.38.4.502

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  A new model of duodenal ulcers induced in rats by diethyldithiocarbamate, a superoxide dismutase inhibitor.

Authors:  H Niida; M Okada; K Takeuchi; S Okabe
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 2.  Tissue destruction by neutrophils.

Authors:  S J Weiss
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

3.  Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation.

Authors:  D C Salo; R E Pacifici; S W Lin; C Giulivi; K J Davies
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

4.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

5.  Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response.

Authors:  G A Visner; W C Dougall; J M Wilson; I A Burr; H S Nick
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

6.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

Authors:  C P Dooley; H Cohen; P L Fitzgibbons; M Bauer; M D Appleman; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

7.  Gastric mucosal protection and superoxide dismutase.

Authors:  K Ogino; S Oka; Y Okazaki; T Takemoto
Journal:  J Clin Gastroenterol       Date:  1988       Impact factor: 3.062

8.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1.

Authors:  C A Harris; K S Derbin; B Hunte-McDonough; M R Krauss; K T Chen; D M Smith; L B Epstein
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

10.  Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

View more
  6 in total

1.  Myeloperoxidase, xanthine oxidase and superoxide dismutase in the gastric mucosa of Helicobacter pylori positive and negative pediatric patients.

Authors:  Mustafa Akcam; Oguz Elmas; Aygen Yilmaz; Serkan Cağlar; Reha Artan; Tekinalp Gelen; Yakup Alicigüzel
Journal:  Mol Cell Biochem       Date:  2006-06-07       Impact factor: 3.396

2.  Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.

Authors:  J M Götz; J L Thio; H W Verspaget; G J Offerhaus; I Biemond; C B Lamers; R A Veenendaal
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

3.  Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2.

Authors:  Qiong Li; Ashok Kumar; Jian-Fang Gui; Fu-Shin X Yu
Journal:  Microb Pathog       Date:  2007-11-28       Impact factor: 3.738

4.  Metallothionein expression in Helicobacter-infected pregnant mice and their fetuses and pups.

Authors:  Cuong D Tran; Rikke Gøbel; Erin L Symonds
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.487

5.  Serum copper/zinc superoxide dismutase (Cu/Zn SOD) and gastric cancer risk: a case-control study.

Authors:  Yingsong Lin; Shogo Kikuchi; Yuki Obata; Kiyoko Yagyu
Journal:  Jpn J Cancer Res       Date:  2002-10

6.  Superoxide dismutases in relation to the overall survival of colorectal cancer patients.

Authors:  A M Janssen; C B Bosman; C F Sier; G Griffioen; F J Kubben; C B Lamers; J H van Krieken; C J van de Velde; H W Verspaget
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.